Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 228

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials

Open access
Sinha, Pratik, Kerchberger, V Eric, Willmore, Andrew, Chambers, Julia, Zhuo, Hanjing, Abbott, Jason, Jones, Chayse, Wickersham, Nancy, Wu, Nelson, Neyton, Lucile, Langelier, Charles R, Mick, Eran, He, June, Jauregui, Alejandra, Churpek, Matthew M, Gomez, Antonio D, Hendrickson, Carolyn M, Kangelaris, Kirsten N, Sarma, Aartik, Leligdowicz, Aleksandra, Delucchi, Kevin L, Liu, Kathleen D, Russell, James A, Matthay, Michael A, Walley, Keith R, Ware, Lorraine B, Calfee, Carolyn S · 2023 · The Lancet Respiratory Medicine

Abstract

Summary Background: In sepsis and acute respiratory distress syndrome (ARDS) heterogeneity has contributed to difficulty identifying effective pharmacotherapies. In ARDS, two molecular phenotypes (“Hypoinflammatory” and “Hyperinflammatory”) have consistently been identified, with divergent outcomes and treatment responses. In this study, we sought to derive molecular phenotypes in critically ill adult sepsis patients, determine their overlap with prior ARDS phenotypes, and whether they respond differently to treatment in completed sepsis trials. Methods: We used clinical data and plasma biomarkers from two prospective sepsis cohorts [VALID (N=1140) and EARLI (N=818)] in latent class analysis (LCA) to identify the optimal number of classes in each cohort independently. We used validated models trained to classify ARDS phenotypes to evaluate concordance of sepsis and ARDS phenotypes. We applied these models to the PROWESS-SHOCK and VASST trials to assign phenotypes and evaluate heterogeneity of treatment. Findings: A two-class model best fit both VALID and EARLI (p<0.0001). In VALID, 804/1140 (71%) were classified as Hypoinflammatory, and 336/1140 (29%) as Hyperinflammatory; in EARLI, the proportions were 530/818 (65%) and 288/818 (35%) respectively. Comparatively, we observed higher plasma pro-inflammatory cytokines, more vasopressor-use, more bacteraemia, lower Protein C, and higher mortality in the Hyperinflammatory phenotype (p<0.0001 for all). Classifier models indicated strong concordance between sepsis phenotypes and previously identified ARDS phenotypes (area under the curve 0.86-0.96, depending on model). Findings were similar excluding participants with both sepsis and ARDS. In PROWESS-SHOCK, 1142/1680 (68%) were Hypoinflammatory and 538/1680 (32%) Hyperinflammatory, and response to activated protein C differed by phenotype (p=0.0043). In VASST, phenotype proportions were similar to other cohorts; however, no treatment interaction with the type of vasopressor was observed (p=0.72). Interpretation: Molecular phenotypes previously identified in ARDS are also identifiable in multiple sepsis cohorts and respond differently to activated protein C. Molecular phenotypes may represent a treatable trait in critical illness beyond the patient’s syndromic diagnosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-2600(23)00237-0

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 228

Metadata

Authors
Sinha, P., Kerchberger, V. E., Willmore, A., Chambers, J., Zhuo, H., Abbott, J., Jones, C., Wickersham, N., Wu, N., Neyton, L., Langelier, C. R., Mick, E., He, J., Jauregui, A., Churpek, M. M., Gomez, A. D., Hendrickson, C. M., Kangelaris, K. N., Sarma, A., Leligdowicz, A., Delucchi, K. L., Liu, K. D., Russell, J. A., Matthay, M. A., Walley, K. R., Ware, L. B., & Calfee, C. S.
Venue
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Published
2023-11
Volume
11
Issue
11
Pages
965-974
ISSN
2213-2600 (ISSN-L)
OpenAlex
W4386102775
Cited by
228
References
5
FWCI
38.13
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. https://app.cochat.ai/papers/10.1016/s2213-2600(23)00237-0
The paper
Sinha, P., Kerchberger, V. E., Willmore, A., Chambers, J., Zhuo, H., Abbott, J., Jones, C., Wickersham, N., Wu, N., Neyton, L., Langelier, C. R., Mick, E., He, J., Jauregui, A., Churpek, M. M., Gomez, A. D., Hendrickson, C. M., Kangelaris, K. N., Sarma, A., . . . Calfee, C. S. (2023). Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(23)00237-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.